TOP TIERMARKET NEWSWIRE
News & sentiment

NRX PHARMACEUTICALS (NRXP) — News & AI sentiment

NRX PHARMACEUTICALS (NRXP) news roundup. 2 stories in the past week, 8 over 30 days. Average 30-day sentiment is 49.8/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 56/100
30d stories
8
avg sentiment 49.8/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

NRXP news in the last 24 hours, 7 days, 30 days and 90 days

How much NRXP coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowNRXP storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days256/100NRXP headlines →
Last 30 days849.8/100NRXP headlines →
Last 90 days2355/100NRXP headlines →

Latest stories on NRXP

2d ago
5d ago
Aug 18
Aug 18
Aug 17
Aug 17
Aug 17
Aug 17
Aug 10
H.C. Wainwright reiterates NRx Pharmaceuticals stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Aug 10
Aug 7
Aug 7
Aug 7
Aug 7
Jul 25
Jul 22
Jul 15
Jun 25
Jun 25
Jun 24
Jun 23
Jun 23
Jun 22
Jun 10
Jun 5
Open NRXP in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →